Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 3, 1996, Pages 565-573

  Narayanan, Shridhar ^a   Willins, David ^a   Dalia, Asad ^a   Wallace, Lane ^a   Uretsky, Norman ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Baclofen; Dopamine; MK 801; Nucleus accumbens; Ventral tegmental area

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BACLOFEN; DIZOCILPINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; RESERPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALIA;

EID: 0029938833     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02220-1     Document Type: Article

References (45)

1. Anden, N. E. Effects of reserpine and a tyrosine hydroxylase inhibitor on monoamine levels in different regions of the rat central nervous system. Eur. J. Pharmacol. 1:1-5; 1967.
2. Beck, K. D.; Knusel, B.; Pasinetti, G.; Michel, P. P.; Zawadzka, H.; Goldstein, M.; Hefti, F. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: Effect of 1-methyl-4-phenylpyridinium treatment. J. Neurochem. 57:527-532; 1991.
3. Bertler, A. Effect of reserpine on the storage of catecholamines in the brain. Acta Physiol. Scand. 51:75-83; 1961.
4. Boldry, R. C.; Willins, D. L.; Wallace, L. J.; Uretsky, N. J. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Brain Res. 559:100-108; 1991.
5. Breese, G. R.; Napier, T. C.; Mueller, R. A. Dopamine-agonist induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: Functional supersenstivity of D1 dopamine receptors in neonatally lesioned rats. J. Pharmacol. Exp. Ther. 234:447-455; 1985.
6. Carlsson, M.; Carlsson, A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 75:221-226; 1989.
7. Carlsson, M.; Carlsson, A. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J. Neural Transm. 77:64-71; 1989.
8. Carlsson, A.; Lindqvist, M.; Magnusson, T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200; 1957.
9. 5H]-dibenzo[a,d] cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug. Dev. Res. 2:134-145; 1982.
10. Clineschmidt, B. V.; Martin, G. E.; Bunting, P. R. Anticonvulsant activity of (±)-5-methyl-10,11-dihydro-[5H]-dibenzo[a,d] cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev. Res. 2:123-134; 1982.
11. Dall'Olio, R.; Gandolfi, O.; Montanaro, N. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Psychopharmacology (Berlin) 107:591-594; 1992.
12. Dall'Olio, R.; Roncada, P.; Vaccheri, A.; Gandolfi, O.; Montanaro, N. Synergistic blockade of some dopamine mediated behaviors by (-)sulpiride and SCH 23390 in the rat. Psychopharmacology (Berlin) 98:342-346; 1989.
13. Dawbarn, D.; Pycock, C. J. Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat. Naunyn Schmiedebergs Arch Pharmacol. 318:100-104; 1981.
14. 10 dopamine neurons. Neurosci. Lett. 119:159-162; 1990.
15. 2 agonists in the reserpinetreated mouse are affected differentially by the NMDA receptor antagonist MK-801. J. Neural Transm. 4:15-26; 1992.
16. Grace, A. A.; Bunney, B. S. The control of the firing pattern of nigral dopamine neurons: burst firing. J. Neurosci. 4:2877-2890; 1984.
17. Hiramattsu, M.; Cho, A. K.; Nabeshima, T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonist MK-801 and phencyclidine. Eur. J. Pharmacol. 166:359-366; 1989.
18. Hiroi, N.; White, N. M. The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm. Brain Res. 510:33-42; 1990.
19. 10 dopamine neurons by aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 253:858-866; 1990.
20. Kalivas, P. W.; Alesdatter, J. E. Involvement of N-methyl-D-aspartate receptor stimulation in ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:486-495; 1993.
21. 3H]-SCH 23390 induced by MK-801 in the mouse striatum. Neuropharmacology 32:341-348; 1993.
22. 2 receptors in rat substantia nigra neurons. J. Physiol. (London) 401: 435-437; 1988.
23. Loscher, W.; Honack, D. The behavioral effects of MK-801 in rats: Involvement of dopaminergic, serotonergic, and noradrenergic systems. Eur. J. Pharmacol. 215:199-208; 1992.
24. Loscher, W.; Annies, R.; Honack, D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increased in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:191-194; 1991.
25. Maj, J.; Rogoz, Z.; Skuza, G. Locomotor hyperactivity induced by MK-801 in rats. Pol. J. Pharmacol. Pharm. 43:449-458; 1991.
26. 2 receptors for the hyperactivity response elicited by MK-801. J. Neural Transm. 95:113-121; 1994.
27. Murase, S.; Mathe, J. M.; Grenhoff, J.; Svensson, T. H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: Differential actions on firing pattern related to anatomical localization. J. Neural Transm. 91:13-25; 1993.
28. Olpe, H. R.; Koella, W. P.; Wolf, P.; Haas, H. L. The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area. Brain Res. 134:577-580; 1977.
29. Ouagazaal, A.-M.; Nieoullon, A.; Amalric, M. Locomotor activation induced by MK-801 in the rat: Postsynaptic interactions with dopamine receptors in the ventral striatum. Eur. J. Pharmacol. 251:229-236; 1994.
30. 2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology (Berlin) 111:427-434; 1993.
31. Paxinos, G.; Watson, C. The rat brain in sterotaxic coordinates. New York: Academic Press; 1986.
32. Pellegrino, L. K.; Pellegrino, A. S.; Cushman, A. J. A stereotaxic atlas of the rat brain. New York: Plenum Press; 1979.
33. Pinnock, R. D. Hyperpolarizing action of baclofen on neurons in the rat substantia nigra slice. Brain Res. 332:337-340; 1984.
34. Raffa, R.; Ortegon, M. E.; Robisch, D. M.; Martin, G. E. In vivo demonstration of the enhancement of MK-801 by l-glutamate. Life Sci. 44:1593-1599; 1989.
35. Rao, T. S.; Kim, H. S.; Lehmann, J.; Martin, L. L.; Wood, P. L. Interactions of the phencyclidine receptor agonist MK-801 with the dopaminergic system; regional studies in the rat. J. Neurochem. 54:1157-1162; 1990.
36. Seutin, V.; Johnson, S. W.; North, R. A. Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience 58:201-206; 1994.
37. 2 dopamine agonists in reserpine-treated mice. Psychopharmacology (Berlin) 114:469-476; 1994.
38. 2 receptor agonists and the NMDA receptor antagonist dizocilpine in monoamine depleted mice. J. Neural Transm. 90:199-217; 1992.
39. Tamminga, C. A.; Gerlach, J. New neuroleptics and experimental antipsychotics in schizophrenia. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987:1129-1140.
40. Tanner, T. GABA-induced locomotor acivity in the rat after bilateral injection into the ventral tegmental area. Neuropharmacology 18:441-446; 1979.
41. Tricklebank, M. D.; Singh, L.; Oles, R. J.; Preston, C.; Iversen, S. D. The behavioral effect of MK-801 : A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:127-135; 1989.
42. Wang, T.; French, E. D. Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: An extracellular in vitro study. Life Sci. 53: 49-56; 1993.
43. 10 dopamine neurons in the ventral tegmental area: In vivo microdialysis and in vitro electrophysiological studies. Brain Res. 666:255-262; 1994.
44. Willins, D. L.; Narayanan, S.; Wallace, L. J.; Uretsky, N. J. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmacol. Biochem. Behav. 46:881-887; 1993.
45. Zhang, J.; Chiodo, L. A.; Freeman, A. S. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590:153-163; 1992.